ISR Immune System Regulation
ISR Holding: Signs an agreement with Catalent Inhalation (Redeye)
2022-06-29 12:56
Redeye is encouraged to learn that ISR has signed an agreement with Catalent Inhalation to scale-up its spray-dried nasal vaccine, powder formulation for its clinical phase III study.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se